IconICLR
ICLR
About: Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
Employees: 41,900
0
Funds holding %
of 7,425 funds
0
Analysts bullish %
of 8 analysts
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
7% more funds holding in top 10
Funds holding in top 10: 15 [Q3] → 16 (+1) [Q4]
1.51% less ownership
Funds ownership: 93.56% [Q3] → 92.05% (-1.51%) [Q4]
11% less funds holding
Funds holding: 653 [Q3] → 581 (-72) [Q4]
26% less repeat investments, than reductions
Existing positions increased: 184 | Existing positions reduced: 250
28% less capital invested
Capital invested by funds: $22.1B [Q3] → $15.9B (-$6.11B) [Q4]
42% less first-time investments, than exits
New positions opened: 88 | Existing positions closed: 152
66% less call options, than puts
Call options by funds: $33.1M | Put options by funds: $96.4M
Research analyst outlook
8 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$150
1%
downside
Avg. target
$187
24%
upside
High target
$215
42%
upside
8 analyst ratings
3 positive
38%
5 neutral
63%
0 negative
0%
JP Morgan Casey Woodring 0% 1-year accuracy 0 / 7 met price target | 1%downside $150 | Neutral Downgraded | 29 Apr 2025 |
TD Cowen Charles Rhyee 13% 1-year accuracy 1 / 8 met price target | 4%upside $157 | Hold Downgraded | 14 Apr 2025 |
Truist Securities Jailendra Singh 34% 1-year accuracy 12 / 35 met price target | 37%upside $208 | Buy Maintained | 10 Apr 2025 |
Barclays Luke Sergott 36% 1-year accuracy 21 / 59 met price target | 9%upside $165 | Equal-Weight Downgraded | 10 Apr 2025 |
Mizuho Ann Hynes 57% 1-year accuracy 12 / 21 met price target | 32%upside $200 | Outperform Maintained | 9 Apr 2025 |
Financial journalist opinion
Based on 137 articles about ICLR published over the past 30 days
Positive
Zacks Investment Research
2 hours ago
Icon PLC (ICLR) Beats Q1 Earnings Estimates
Icon PLC (ICLR) came out with quarterly earnings of $3.19 per share, beating the Zacks Consensus Estimate of $3.08 per share. This compares to earnings of $3.47 per share a year ago.
Neutral
Business Wire
5 hours ago
ICON Reports First Quarter 2025 Results
DUBLIN--(BUSINESS WIRE)--ICON Reports First Quarter 2025 Results.
Neutral
Zacks Investment Research
1 day ago
What to Expect From These 3 MedTech Stocks This Earnings Season?
Here is a sneak peek into how these three MedTech stocks, ALGN, TNDM and ICLR, may fare in their quarterly results, slated to be released tomorrow.
Neutral
PRNewsWire
1 day ago
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES , April 29, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company ("ICON" or "the Company") (NASDAQ: ICLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 27, 2023 and October 23, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before June 2, 2025.
Neutral
PRNewsWire
6 days ago
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES , April 24, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company ("ICON" or "the Company") (NASDAQ: ICLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 27, 2023 and October 23, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before June 2, 2025.
Negative
Zacks Investment Research
1 week ago
Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for
Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Positive
24/7 Wall Street
1 week ago
3 Value Stocks Set to Surge, With Up to 190% Upside in 2025
The relentless bull run led by high-flying growth stocks is no longer here, and 2025 has brought a significant shift in the market landscape, with the S&P 500 now in correction territory.
Neutral
PRNewsWire
2 weeks ago
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES , April 14, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company ("ICON" or "the Company") (NASDAQ: ICLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 27, 2023 and October 23, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before June 2, 2025.
Neutral
Accesswire
2 weeks ago
ICON Public Limited Company Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 11, 2025 to Discuss Your Rights - ICLR
NEW YORK, NY / ACCESS Newswire / April 11, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=142601&wire=1 or contact Joseph E. Levi, Esq.
Neutral
Accesswire
2 weeks ago
Shareholders of ICON Public Limited Company Should Contact Levi & Korsinsky Before April 11, 2025 to Discuss Your Rights - ICLR
NEW YORK, NY / ACCESS Newswire / April 11, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=142581&wire=1 or contact Joseph E. Levi, Esq.
Charts implemented using Lightweight Charts™